16-23607862-G-T
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PVS1PM2PP5_Moderate
The NM_024675.4(PALB2):c.3350+2C>A variant causes a splice donor, intron change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 1/1 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Likely pathogenic (★).
Frequency
Consequence
NM_024675.4 splice_donor, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 12 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Familial cancer of breast Pathogenic:1
This variant is considered likely pathogenic. This variant occurs within a consensus splice junction and is predicted to result in abnormal mRNA splicing of either an out-of-frame exon or an in-frame exon necessary for protein stability and/or normal function. -
Hereditary cancer-predisposing syndrome Pathogenic:1
This variant causes a C to A nucleotide substitution at the +2 position of intron 12 of the PALB2 gene. Splice site prediction tool predicts that this variant may have a significant impact on RNA splicing. Two different substitutions, c.3350+1G>A and c.3350+5G>A, that are similarly predicted to weaken or disrupt this donor site have been reported to cause the out-of-frame skipping of exon 12 and the predicted disruption to the functionally important WD40 domain in the variant PALB2 protein (PMID: 30890586, 32238468, 34846068). To our knowledge, this variant has not been reported in individuals affected with PALB2-associated disorder in the literature. However, c.3350+2C>G and c.3350+1G>A, have been reported as (likely) disease-causing in ClinVar (variation ID: 219641, 492218), and c.3350+5G>A has been reported in a homozygous carrier affected with Fanconi anemia (PMID: 32238468). This variant has not been identified in the general population by the Genome Aggregation Database (gnomAD). Based on the available evidence, this variant is classified as Likely Pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.